تداخلات ميثيل تستوستيرون

To date, epidemiologic studies and randomized controlled trials have been inconclusive for determining the risk of major adverse cardiovascular events (MACE), such as non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death, with the use of testosterone compared to non-use. (نشرة ميثيل تستوستيرون، التحذيرات)

These drugs include, but are not limited to, the following: the anticonvulsants carbamazepine, oxcarbazepine, phenobarbital, phenytoin the androgen receptor inhibitor enzalutamide the antimycobacterials rifampin, rifapentine the cytotoxic agent mitotane St. (نشرة دورافيرين، موانع الاستعمال)

Because of the ability of Type II 5α-reductase inhibitors to inhibit the conversion of testosterone to 5α-dihydrotestosterone (DHT), finasteride may cause abnormalities of the external genitalia of a male fetus of a pregnant female who receives finasteride. (نشرة فيناستيريد، موانع الاستعمال)

CONTRAINDICATIONS: Precocious puberty, prostatic carcinoma or other androgen-dependent neoplasm, prior allergic reaction to HCG. (نشرة موجهة الغدد التناسلية المشيمائية، موانع الاستعمال)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (نشرة ميثيل تستوستيرون، التداخلات الدوائية)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (نشرة ميثيل تستوستيرون، التداخلات الدوائية)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

Free hormone concentrations, such as testosterone and estradiol, may be decreased. (نشرة إستراديول ونوريثيستيرون، التحذيرات والاحتياطات)

Free hormone concentrations, such as testosterone and estradiol, may be decreased. (نشرة إستروجينات مقترنة، الاحتياطات)

Free hormone concentrations, such as testosterone and estradiol, may be decreased. (نشرة إستروجينات مقترنة وبازيدوكسيفين، التحذيرات والاحتياطات)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (نشرة ميثيل تستوستيرون، التداخلات الدوائية)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (نشرة ميثيل تستوستيرون، التداخلات الدوائية)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (نشرة ميثيل تستوستيرون، التداخلات الدوائية)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (نشرة ميثيل تستوستيرون، التداخلات الدوائية)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (نشرة ميثيل تستوستيرون، التداخلات الدوائية)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (نشرة ميثيل تستوستيرون، التداخلات الدوائية)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (نشرة ميثيل تستوستيرون، التداخلات الدوائية)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (نشرة ميثيل تستوستيرون، التداخلات الدوائية)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (نشرة ميثيل تستوستيرون، التداخلات الدوائية)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

…anti-diabetic medications, pramlintide acetate, insulin, angiotensin converting enzyme (ACE) inhibitors, H2 receptor antagonists, fibrates, propoxyphene, pentoxifylline, somatostatin analogs, anabolic steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs… (نشرة بيوغليتازون وغليميبيريد، التداخلات الدوائية)

Hypercalcemia in Patients with Metastatic Breast Cancer As with other additive hormonal therapy (estrogens and androgens), hypercalcemia has been reported in some breast cancer patients with bone metastases within a few weeks of starting treatment with tamoxifen. (نشرة تاموكسيفين، التحذيرات والاحتياطات)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

Tumor Flare: Transient increase in serum testosterone levels can occur within the first few weeks of treatment. (نشرة تريبتوريلين، التحذيرات والاحتياطات)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (نشرة ميثيل تستوستيرون، التداخلات الدوائية)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (نشرة ميثيل تستوستيرون، التداخلات الدوائية)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

Reproductive effects: Include decreased testosterone and increased prolactin levels. (نشرة راميلتيون، التحذيرات والاحتياطات)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (نشرة ميثيل تستوستيرون، التداخلات الدوائية)

Abiraterone: Spironolactone binds to the androgen receptor and may increase prostate‑specific antigen (PSA) levels in abiraterone-treated prostate cancer patients. (نشرة سبيرونولاكتون وهيدروكلوروثيازيد، التداخلات الدوائية)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

…medications, pramlintide acetate, insulin, angiotensin converting enzyme (ACE) inhibitors, H 2 receptor antagonists, fibrates, propoxyphene, pentoxifylline, somatostatin analogs, anabolic steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs… (نشرة غليميبيريد، التداخلات الدوائية)

Effect on QT/QTc Interval: Androgen deprivation therapy may prolong the QT interval. (نشرة غوسيريلين، التحذيرات والاحتياطات)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

For Men : Clinical monitoring for spermatogenesis utilizes the following indirect or direct measures: Serum testosterone level Semen analysis 5.11 FOLLISTIM Pen The FOLLISTIM Pen is intended only for use with FOLLISTIM AQ Cartridge. (نشرة فوليتروبين، التحذيرات والاحتياطات)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (نشرة ميثيل تستوستيرون، التداخلات الدوائية)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

PRECAUTIONS General Induction of androgen secretion by hCG may cause fluid retention. (نشرة كوريوغونادوتروبين ألفا، الاحتياطات)

However, clinical studies have shown that lovastatin does not reduce basal plasma cortisol concentration or impair adrenal reserve, and does not reduce basal plasma testosterone concentration. (نشرة لوفاستاتين، التداخلات الدوائية)

Androgens/Anabolic Steroids Asparaginase Glucocorticoids Slow-Release Nictonic Acid These drugs may decrease serum TBG concentration. (نشرة ليفوثيروكسين، التداخلات الدوائية)

Tumor Flare: Increased serum testosterone (~ 50% above baseline) may occur when initiating treatment with LUPRON DEPOT. (نشرة ليوبروليد، التحذيرات والاحتياطات)

Androgens/Anabolic Steroids Asparaginase Glucocorticoids Slow-Release Nicotinic Acid These drugs may decrease serum TBG concentration. (نشرة ليوثيرونين، التداخلات الدوائية)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

The following laboratory tests may be affected by progestins including MPA Injectable Suspension, USP: (a) Plasma and urinary steroid levels are decreased (e.g., progesterone, estradiol, pregnanediol, testosterone, cortisol). (نشرة ميدروكسي بروجستيرون، التداخلات الدوائية)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (نشرة ميثيل تستوستيرون، التداخلات الدوائية)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (نشرة ميثيل تستوستيرون، التحذيرات)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (نشرة ميثيل تستوستيرون، التداخلات الدوائية)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

Free thyroid hormone levels remain unchanged, however, and there is no clinical evidence of thyroid dysfunction. (نشرة ميثيل تستوستيرون، الاحتياطات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

Free thyroid hormone levels remain unchanged, however, and there is no clinical evidence of thyroid dysfunction. (نشرة ميثيل تستوستيرون، الاحتياطات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

Free thyroid hormone levels remain unchanged, however, and there is no clinical evidence of thyroid dysfunction. (نشرة ميثيل تستوستيرون، الاحتياطات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)

Free thyroid hormone levels remain unchanged, however, and there is no clinical evidence of thyroid dysfunction. (نشرة ميثيل تستوستيرون، الاحتياطات)

In addition to discontinuation of the drug, diuretic therapy may be required. (نشرة ميثيل تستوستيرون، التحذيرات)